This brand name is authorized in Estonia, Lithuania
The drug DOTAGITA contains one active pharmaceutical ingredient (API):
|
1
Gadoteric acid
UNII L0ND3981AG - GADOTERATE MEGLUMINE
|
|
Gadoteric acid has paramagnetic properties allowing MRI contrast enhancement. It has no specific pharmacodynamic activity and is biologically very inert. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V08CA02 | Gadoteric acid | V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1611526, 1611650, 1611661, 1611672, 1611683, 1611694, 1611706, 1611717, 1611728, 1611739 |
| Country: LT | Valstybinฤ vaistลณ kontrolฤs tarnyba | Identifier(s): 1069876, 1074225, 1074226, 1074227, 1074228, 1074229, 1074230, 1074231, 1074232, 1074233 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
